Skip to the page

Data / Form D filings / Savannah Therapeutics, Inc

Savannah Therapeutics, Inc: Form D filing

Savannah Therapeutics, Inc, a health care company in Riverdale, MD, filed a Form D with the SEC in 2026. The latest, on September 11, 2026, reports $3.9 million sold of a $6 million offering to 28 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
5650 Rivertech Court Suite 20, Riverdale, MD, 20737
Phone
(651) 491-0507
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2026
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2149298

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 11, 2026New notice$6,000,000$3,855,000$2,145,00028Apr 17, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Thomas WollanExecutive Officer
Matthew DowlingDirector

Other health care companies in Maryland that filed recently

Every Form D from the week of Sep 7, 2026 · All recent filings in Maryland · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Savannah Therapeutics, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.